Dr. Barken introduces the New Prostate Cancer Immune Therapy for earlier stages of Prostate Cancer.  Please watch the video below and see what  he learned at the National Cancer Institute recent conference mentioned above.

Dr. James Gulley explains the Prostvac approach.

Prostvac and Enzalutamide for patients who have biochemical recurrence after surgery or radiation.   copy and paste the url – http://clinicaltrials.gov/ct2/show/NCT01875250?term=Prostvac+Phase+III&rank=4